A Retrospective Analysis of the Effect of Combination of Pure Fish Oil with Third Generation Lipid Emulsion on Liver Function in Children on Long-Term Parenteral Nutrition
Open Access
- 17 October 2019
- Vol. 11 (10), 2495
- https://doi.org/10.3390/nu11102495
Abstract
Background: Deterioration of liver function, or intestinal failure-associated liver disease, is often observed in long-term parenterally fed children. Fish oil-based intravenous lipids have been reported to play a role in the prevention and treatment of intestinal failure associated liver disease. Methods: This retrospective analysis included 40 pediatric patients, (20 male and 20 female), median age 38 months (range 1.5–200 months) on long-term (≥1 month) parenteral nutrition who received the parenteral mixtures containing a combination of a third-generation lipid emulsion and pure fish oil because of laboratory liver function abnormalities. The total dose of fish oil from both emulsions for each patient exceeded 0.5 g/kg/day. Data from visits in an outpatient clinic were retrospectively analyzed using the Wilcoxon test, Mann-Whitney test, and Spearman correlation test. Results: The median time of therapy was 149 days (range 28–418 days). There was a decrease of median total and direct (conjugated) bilirubin concentration from 22.23 µmol/L (range 3.42–243 µmol/L) to 10.26 µmol/L (range 3.42–180.58 µmol/L; p < 0.005) and 8.55 (range 1.71–212.04 µmol/L) to 6.84 µmol/L (range 1.71–150.48 µmol/L; p < 0.007) respectively. A significant decrease in median alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase was also observed. In 11 patients bilirubin concentrations increased or remained unchanged. When compared to the patients who responded to the combination therapy, the patients who did not respond received parenteral nutrition for a longer time prior to the start of the therapy (51 vs. 30 months; p < 0.05). Conclusions: The mixture of an intravenous lipid emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil with the addition of pure fish oil emulsion may be helpful in the treatment of liver complications in children on long-term parenteral nutrition.This publication has 50 references indexed in Scilit:
- Lipid emulsions for parenterally fed term and late preterm infantsEmergencias, 2019
- Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric PatientsJournal of Parenteral and Enteral Nutrition, 2016
- Preservation of Biochemical Liver Function With Low‐Dose Soy‐Based Lipids in Children With Intestinal Failure–Associated Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2015
- Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failureJournal of Hepatology, 2015
- The Natural History of Cirrhosis From Parenteral Nutrition-Associated Liver Disease After Resolution of Cholestasis With Parenteral Fish Oil TherapyAnnals of Surgery, 2015
- Hepatic Explant Pathology of Pediatric Intestinal Transplant Recipients Previously Treated with Omega-3 Fatty Acid Lipid EmulsionThe Journal of Pediatrics, 2014
- Hepatic Fibrosis Persists and Progresses Despite Biochemical Improvement in Children Treated With Intravenous Fish Oil EmulsionJournal of Pediatric Gastroenterology and Nutrition, 2013
- Omega-3 Long Chain Polyunsaturated Fatty Acids for Treatment of Parenteral Nutrition–Associated Liver Disease: A Review of the LiteratureThe Journal of Pediatric Pharmacology and Therapeutics, 2011
- Safety and Efficacy of a Lipid Emulsion Containing a Mixture of Soybean Oil, Medium‐chain Triglycerides, Olive Oil, and Fish Oil: A Randomised, Double‐blind Clinical Trial in Premature Infants Requiring Parenteral NutritionJournal of Pediatric Gastroenterology and Nutrition, 2010
- A New Intravenous Fat Emulsion Containing Soybean Oil, Medium‐Chain Triglycerides, Olive Oil, and Fish OilJournal of Parenteral and Enteral Nutrition, 2010